Asthma as a risk factor for invasive pneumococcal disease. Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, Schaffner W, Craig AS, Griffin MR (2005) N Engl J Med 352: 2082-90 Decrease in antibiotic use, an added benefit of PCVs. Grijalva CG (2014) Lancet Infect Dis 14: 175-7 Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data? Grijalva CG, Moore MR, Griffin MR (2011) Lancet Infect Dis 11: 724-6 Restraining the pneumococcus. Griffin MR, Grijalva CG (2015) Lancet Infect Dis 15: 491-2 Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases: A Nested Case-Control Study. Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel EF, Grijalva CG (2018) Ann Intern Med 168: 396-404 Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays. Wunderink RG, Self WH, Anderson EJ, Balk R, Fakhran S, Courtney DM, Qi C, Williams DJ, Zhu Y, Whitney CG, Moore MR, Bramley A, Jain S, Edwards KM, Grijalva CG (2018) Clin Infect Dis 66: 1504-1510 Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR (2004) Clin Infect Dis 39: 641-8 Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia. Peters TR, Brumbaugh DE, Lawton AR, Crowe JE (2000) Clin Infect Dis 31: 1287-8 Changes in Otitis Media Episodes and Pressure Equalization Tube Insertions Among Young Children Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Birth Cohort-based Study. Wiese AD, Huang X, Yu C, Mitchel EF, Kyaw MH, Griffin MR, Grijalva CG (2019) Clin Infect Dis 69: 2162-2169 To Boost or Not to Boost? Lessons from the Australian Pneumococcal Conjugate Vaccination Program. Wiese AD, Grijalva CG (2020) Clin Infect Dis 70: 2616-2618 Promises and challenges of pneumococcal conjugate vaccines for the developing world. Grijalva CG, Edwards KM (2006) Clin Infect Dis 43: 680-2 Cohort profile: The study of respiratory pathogens in Andean children. Grijalva CG, Griffin MR, Edwards KM, Williams JV, Gil AI, Verastegui H, Hartinger SM, Vidal JE, Klugman KP, Lanata CF (2014) Int J Epidemiol 43: 1021-30 Nasopharyngeal Pneumococcal Density during Asymptomatic Respiratory Virus Infection and Risk for Subsequent Acute Respiratory Illness. Howard LM, Zhu Y, Griffin MR, Edwards KM, Williams JV, Gil AI, Vidal JE, Klugman KP, Lanata CF, Grijalva CG (2019) Emerg Infect Dis 25: 2040-2047 Nasopharyngeal Pneumococcal Density and Evolution of Acute Respiratory Illnesses in Young Children, Peru, 2009-2011. Fan RR, Howard LM, Griffin MR, Edwards KM, Zhu Y, Williams JV, Vidal JE, Klugman KP, Gil AI, Lanata CF, Grijalva CG (2016) Emerg Infect Dis 22: 1996-1999 Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B (2010) J Infect Dis 202: 1287-95 Unveiling the burden of influenza-associated pneumococcal pneumonia. Grijalva CG, Griffin MR (2012) J Infect Dis 205: 355-7 Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era. de St Maurice A, Schaffner W, Griffin MR, Halasa N, Grijalva CG (2016) J Infect Dis 214: 792-7 Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. Braun JS, Novak R, Murray PJ, Eischen CM, Susin SA, Kroemer G, Halle A, Weber JR, Tuomanen EI, Cleveland JL (2001) J Infect Dis 184: 1300-9 Distribution of pneumococcal serotypes in adult pneumococcal pneumonia cases: filling the evidence gap to inform vaccination policies. Griffin MR, Grijalva CG (2013) J Infect Dis 208: 1734-6 Corynebacterium accolens Releases Antipneumococcal Free Fatty Acids from Human Nostril and Skin Surface Triacylglycerols. Bomar L, Brugger SD, Yost BH, Davies SS, Lemon KP (2016) mBio 7: e01725-15 Effect of replacing cefotaxime with ceftizoxime in a hospital where penicillin-resistant pneumococcal disease is prevalent. Haas DW, Bonczar T (1996) J Antimicrob Chemother 38: 293-9 Racial and Regional Differences in Rates of Invasive Pneumococcal Disease. de St Maurice A, Grijalva CG, Fonnesbeck C, Schaffner W, Halasa NB (2015) Pediatrics 136: e1186-94 No increased risk for invasive bacterial infection found following diphtheria-tetanus-pertussis immunization. Griffin MR, Taylor JA, Daugherty JR, Ray WA (1992) Pediatrics 89: 640-2 National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, Griffin MR (2006) Pediatrics 118: 865-73 Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, Barth RD, Nuorti JP, Griffin MR (2007) Pediatrics 119: 707-15 Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. Alymova IV, Green AM, van de Velde N, McAuley JL, Boyd KL, Ghoneim HE, McCullers JA (2011) J Virol 85: 12324-33 Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, Schaffner W, Craig AS, Griffin MR (2005) Am J Med 118: 285-91 Adherence to prophylactic antibiotic guidelines among Medicaid infants with sickle cell disease. Warren MD, Arbogast PG, Dudley JA, Kaltenbach L, Ray WA, Wang WC, Cooper WO (2010) Arch Pediatr Adolesc Med 164: 298-9 Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. Grijalva CG, Griffin MR (2008) Expert Rev Vaccines 7: 83-95 The human polymeric immunoglobulin receptor facilitates invasion of epithelial cells by Streptococcus pneumoniae in a strain-specific and cell type-specific manner. Brock SC, McGraw PA, Wright PF, Crowe JE (2002) Infect Immun 70: 5091-5 Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA (2006) Infect Immun 74: 2562-7 Rapidly increasing prevalence of penicillin-resistant Streptococcus pneumoniae in middle Tennessee: a 10-year clinical and molecular analysis. Tang YW, Li H, Griffin JP, Haas DW, D'Agata EM (2002) J Clin Microbiol 40: 395-9 Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. Bjornson AB, Falletta JM, Verter JI, Buchanan GR, Miller ST, Pegelow CH, Iyer RV, Johnstone HS, DeBaun MR, Wethers DL, Wang WC, Woods GM, Holbrook CT, Becton DL, Kinney TR, Reaman GH, Kalinyak K, Grossman NJ, Vichinsky E, Reid CD (1996) J Pediatr 129: 828-35 Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease. Lingappa JR, Dumitrescu L, Zimmer SM, Lynfield R, McNicholl JM, Messonnier NE, Whitney CG, Crawford DC (2011) PLoS One 6: e23413 Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7. Hanke CR, Grijalva CG, Chochua S, Pletz MW, Hornberg C, Edwards KM, Griffin MR, Verastegui H, Gil AI, Lanata CF, Klugman KP, Vidal JE (2016) Pediatr Infect Dis J 35: 432-9 Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR (2004) Pediatr Infect Dis J 23: 726-31 Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee. Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W (2013) Pediatr Infect Dis J 32: 604-9 Healthcare utilization and cost of pneumococcal disease in the United States. Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA (2011) Vaccine 29: 3398-412 A computerized pneumococcal vaccination reminder system in the adult emergency department. Dexheimer JW, Talbot TR, Ye F, Shyr Y, Jones I, Gregg WM, Aronsky D (2011) Vaccine 29: 7035-41 Efferocytosis-induced prostaglandin E2 production impairs alveolar macrophage effector functions during Streptococcus pneumoniae infection. Salina AC, Souza TP, Serezani CH, Medeiros AI (2017) Innate Immun 23: 219-227
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.